Search

George Miller Jr

Examiner (ID: 13348)

Most Active Art Unit
2106
Art Unit(s)
2106, 2108, 2605, 3307, 2101, 2305
Total Applications
1640
Issued Applications
1557
Pending Applications
1
Abandoned Applications
82

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17111737 [patent_doc_number] => 20210292334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 17/255451 [patent_app_country] => US [patent_app_date] => 2018-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16044 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255451 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/255451
Triazolotriazine derivatives as A2A receptor antagonists Jun 25, 2018 Issued
Array ( [id] => 17185170 [patent_doc_number] => 20210332055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 17/255464 [patent_app_country] => US [patent_app_date] => 2018-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36039 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255464 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/255464
Triazolotriazine derivatives as A2A receptor antagonists Jun 25, 2018 Issued
Array ( [id] => 16718476 [patent_doc_number] => 20210085623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => Formulation [patent_app_type] => utility [patent_app_number] => 16/610193 [patent_app_country] => US [patent_app_date] => 2018-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6895 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610193 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/610193
Formulation Apr 29, 2018 Pending
Array ( [id] => 16777971 [patent_doc_number] => 20210115048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => HETEROCYCLIC COMPOUND [patent_app_type] => utility [patent_app_number] => 16/608723 [patent_app_country] => US [patent_app_date] => 2018-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23020 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608723 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/608723
HETEROCYCLIC COMPOUND Apr 25, 2018 Pending
Menu